Page last updated: 2024-08-26

bosentan anhydrous and Hemangioma, Capillary

bosentan anhydrous has been researched along with Hemangioma, Capillary in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adachi, S; Hirashiki, A; Kondo, T; Matsubara, H; Miyaji, K; Murohara, T; Nakaguro, M; Ogawa, A; Yokoi, T1
Brasch, F; Bucher, B; Casaulta, C; Griese, M; Navarini, S; Pavlovic, M; Pfammatter, JP; Regamey, N1

Other Studies

2 other study(ies) available for bosentan anhydrous and Hemangioma, Capillary

ArticleYear
Imatinib is partially effective for the treatment of pulmonary capillary hemangiomatosis.
    Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:6

    Topics: Adult; Antihypertensive Agents; Antineoplastic Agents; Autopsy; Benzamides; Bosentan; Cardiac Catheterization; Dyspnea; Echocardiography; Epoprostenol; Fatal Outcome; Hemangioma, Capillary; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Lung; Lung Neoplasms; Male; Piperazines; Purines; Pyrimidines; Radiography, Thoracic; Sildenafil Citrate; Sulfonamides; Treatment Failure

2014
Pulmonary hypertension presenting with apnea, cyanosis, and failure to thrive in a young child.
    Chest, 2011, Volume: 140, Issue:4

    Topics: Antihypertensive Agents; Apnea; Biopsy; Bosentan; Cyanosis; Failure to Thrive; Familial Primary Pulmonary Hypertension; Fatal Outcome; Female; Hemangioma, Capillary; Humans; Hypertension, Pulmonary; Infant; Lung; Lung Neoplasms; Radiography, Thoracic; Sulfonamides

2011